Loading clinical trials...
Loading clinical trials...
A study to determine the optimal dose and blood level of Prograf® in long-term maintenance of kidney transplant patients.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Astellas Pharma Inc
Collaborators
NCT07294183 · Renal Transplantation
NCT06674031 · Chronic Kidney Disease(CKD), Renal Transplantation
NCT06706492 · Renal Transplantation
NCT05086003 · Renal Transplantation
NCT03478215 · Renal Transplantation, Mesenchymal Stem Cells
Birmingham, Alabama
Little Rock, Arkansas
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions